Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  dihydro-5-azacytidine
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-13 of 13 for your search:
Start Over
Phase II Chemotherapy with DHAC for Advanced Adult non-Small Cell Carcinoma of the Bronchus
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CHNMC-IRB-4205, NCI-T84-0414D, T84-0414
Phase II Chemotherapy with DHAC in Patients with non-Small Cell or Small Cell Bronchogenic Carcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: 15 and over
Sponsor: NCI
Protocol IDs: MDA-DM-8466, NCI-T84-0494C, T84-0494
Phase II Chemotherapy with DHAC in Patients with Metastatic Adenocarcinoma of the Colon (Summary Last Modified 10/88)
Phase: Phase II
Type: Treatment
Status: Completed
Age: over 18
Sponsor: NCI
Protocol IDs: OSU-84HO272, OSU-8507, NCI-T85-0008D, T85-0008
Phase II Master Protocol for the Study of New Agents in the Treatment of Metastatic Adenocarcinoma of the Breast --- DHAC
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: ICC-86B1, NCI-T86-0076D, T86-0076
Phase II Study of Dihydro-5-azacytidine in Patients with Malignant Mesothelioma (Summary Last Modified 05/89)
Phase: Phase II
Type: Treatment
Status: Closed
Age: 15 to 80
Sponsor: NCI
Protocol IDs: MDA-DM-8654, NCI-T86-0154C, T86-0154
Phase II Master Protocol for the Study of New Agents in Patients with Ovarian Carcinoma of Coelomic Epithelial Origin --- DHAC (Summary Last Modified 05/88)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 75
Sponsor: NCI
Protocol IDs: ICC-86G1, NCI-T86-0246D, T86-0246
Phase II Study of Dihydro-5-azacytidine in Patients with Malignant Mesothelioma (Summary Last Modified 12/91)
Phase: Phase II
Type: Treatment
Status: Closed
Age: any age
Sponsor: NCI
Protocol IDs: SWOG-8842
Phase II Chemotherapy with Dihydro-5-azacytidine in Patients with Advanced Malignant Melanoma (Summary Last Modified 11/91)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MAYO-877007, NCI-T88-0024D, T88-0024
Phase II Master Protocol for Chemotherapy in Patients with Malignant Mesothelioma --- Dihydro-5-Azacytidine
Phase: Phase II
Type: Treatment
Status: Completed
Age: over 15
Sponsor: NCI
Protocol IDs: CLB-8833, CALGB-8833
Phase II Master Protocol for Chemotherapy in Patients with Malignant Mesothelioma --- DHAC plus CDDP
Phase: Phase II
Type: Treatment
Status: Completed
Age: over 15
Sponsor: NCI
Protocol IDs: CLB-9031, CALGB-9031
Phase I Study of Dihydro-5-Azacytidine
Phase: Phase I
Type: Treatment
Status: Closed
Age: 14 and over
Sponsor:
Protocol IDs: NCI-W82-0538, CTEPIS-0056
Phase I and Pharmacokinetic Study of Dihydro-5-Azacytidine Hydrochloride (NSC-264880)
Phase: Phase I
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: NCI-82-C-173, NCI-W82-1273, W82-1273
Phase I Pharmacokinetic Study of Dihydro-5-Azacytidine HCl (NSC-264880)
Phase: Phase I
Type: Treatment
Status: Closed
Age: over 18
Sponsor:
Protocol IDs: NCI-W82-0560, OSU-IOU-8207, W82-0560
Start Over